{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:10:46Z","timestamp":1790424646209,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019006","name":"State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109887","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:02:35Z","timestamp":1776351755000},"page":"109887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of pyranone\u2013carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease"],"prefix":"10.1016","volume":"176","author":[{"given":"Xueyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Cheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijun","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109887_bb0005","doi-asserted-by":"crossref","first-page":"115297","DOI":"10.1016\/j.ejmech.2023.115297","article-title":"Targeting the multifaceted neurotoxicity of alzheimer\u2019s disease by tailored functionalisation of the curcumin scaffold","volume":"252","author":"De Lorenzi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106663","article-title":"Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3beta inhibitors for alzheimer\u2019s disease","volume":"138","author":"Yan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0015","doi-asserted-by":"crossref","first-page":"116794","DOI":"10.1016\/j.ejmech.2024.116794","article-title":"Design, synthesis, and biological evaluation of imidazolylacetophenone oxime derivatives as novel brain-penetrant agents for alzheimer\u2019s disease treatment","volume":"278","author":"Bian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109887_bb0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.apsb.2023.10.015","article-title":"MiR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of alzheimer\u2019s disease","volume":"14","author":"Luo","year":"2024","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.bioorg.2026.109887_bb0025","doi-asserted-by":"crossref","first-page":"115817","DOI":"10.1016\/j.ejmech.2023.115817","article-title":"Targeting protein kinases for the treatment of alzheimer\u2019s disease: recent progress and future perspectives","volume":"261","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109887_bb0030","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1002\/alz.13089","article-title":"The Alzheimer\u2019s disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology","volume":"19","author":"Samuels","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2026.109887_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106595","article-title":"Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of alzheimer\u2019s disease","volume":"187","author":"Vellecco","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109887_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuron.2022.10.021","article-title":"Microglial piezo1 senses abeta fibril stiffness to restrict alzheimer\u2019s disease","volume":"111","author":"Hu","year":"2022","journal-title":"Neuron."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109887_bb0045","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.apsb.2024.03.034","article-title":"Monoclonal antibodies and aptamers: the future therapeutics for alzheimer\u2019s disease","volume":"14","author":"Barrera-Ocampo","year":"2024","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.bioorg.2026.109887_bb0050","doi-asserted-by":"crossref","first-page":"116099","DOI":"10.1016\/j.ejmech.2023.116099","article-title":"Synthesis and evaluation of butylphthalide-scutellarein hybrids as multifunctional agents for the treatment of alzheimer\u2019s disease","volume":"265","author":"Yu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0055","doi-asserted-by":"crossref","first-page":"116070","DOI":"10.1016\/j.ejmech.2023.116070","article-title":"Curcumin hybrid molecules for the treatment of alzheimer\u2019s disease: structure and pharmacological activities","volume":"265","author":"Zang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109887_bb0060","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.apsb.2022.01.017","article-title":"Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates tau pathology: implications for alzheimer\u2019s disease therapy","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.bioorg.2026.109887_bb0065","doi-asserted-by":"crossref","first-page":"115670","DOI":"10.1016\/j.ejmech.2023.115670","article-title":"Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of alzheimer\u2019s disease","volume":"259","author":"Gutti","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0070","doi-asserted-by":"crossref","first-page":"116810","DOI":"10.1016\/j.ejmech.2024.116810","article-title":"Dual-target inhibitors based on acetylcholinesterase: novel agents for alzheimer\u2019s disease","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106301","article-title":"The metal ion hypothesis of alzheimer\u2019s disease and the anti-neuroinflammatory effect of metal chelators","volume":"131","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109887_bb0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-023-02750-9","article-title":"Decrease in naturally occurring antibodies against epitopes of alzheimer\u2019s disease (AD) risk gene products is associated with cognitive decline in AD","volume":"20","author":"Gu","year":"2023","journal-title":"J. Neuroinflammation."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109887_bb0085","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s41467-023-37304-3","article-title":"An aging, pathology burden, and glial senescence build-up hypothesis for late onset alzheimer\u2019s disease","volume":"14","author":"Lau","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109887_bb0090","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.immuni.2022.07.004","article-title":"Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration","volume":"55","author":"Silvin","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2026.109887_bb0095","doi-asserted-by":"crossref","unstructured":"D.K. Waiker, A. Verma, T.A. Gajendra, Namrata, A. Roy, P. Kumar, S.K. Trigun, S. Srikrishna, S. Krishnamurthy, V.J. Davisson, S.K. Shrivastava, Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for alzheimer\u2019s disease therapy, Eur. J. Med. Chem. 271 (2024) 116409.","DOI":"10.1016\/j.ejmech.2024.116409"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109887_bb0100","doi-asserted-by":"crossref","first-page":"2313682","DOI":"10.1080\/14756366.2024.2313682","article-title":"Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating alzheimers disease","volume":"39","author":"Yu","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"7638","key":"10.1016\/j.bioorg.2026.109887_bb0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature."},{"issue":"7869","key":"10.1016\/j.bioorg.2026.109887_bb0110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","article-title":"Astrocytic interleukin-3 programs microglia and limits alzheimer\u2019s disease","volume":"595","author":"McAlpine","year":"2021","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109887_bb0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of alzheimer\u2019s disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109887_bb0120","doi-asserted-by":"crossref","first-page":"115803","DOI":"10.1016\/j.ejmech.2023.115803","article-title":"Galantamine-memantine hybrids for alzheimer\u2019s disease: the influence of linker rigidity in biological activity and pharmacokinetic properties","volume":"261","author":"Basagni","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0125","doi-asserted-by":"crossref","first-page":"116450","DOI":"10.1016\/j.ejmech.2024.116450","article-title":"Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for alzheimer\u2019s disease treatment","volume":"271","author":"Verma","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0130","doi-asserted-by":"crossref","first-page":"114606","DOI":"10.1016\/j.ejmech.2022.114606","article-title":"Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against alzheimer\u2019s disease","volume":"240","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0135","doi-asserted-by":"crossref","first-page":"115766","DOI":"10.1016\/j.ejmech.2023.115766","article-title":"Discovery of novel benzofuran-based derivatives as acetylcholinesterase inhibitors for the treatment of alzheimer\u2019s disease: design, synthesis, biological evaluation, molecular docking and 3D-QSAR investigation","volume":"260","author":"Abd El-Karim","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0140","doi-asserted-by":"crossref","first-page":"116463","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of alzheimer\u2019s disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0145","doi-asserted-by":"crossref","first-page":"115253","DOI":"10.1016\/j.ejmech.2023.115253","article-title":"Development of the \u201chidden\u201d multi-target-directed ligands by AChE\/BuChE for the treatment of alzheimer\u2019s disease","volume":"251","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0150","doi-asserted-by":"crossref","first-page":"116071","DOI":"10.1016\/j.ejmech.2023.116071","article-title":"Design, synthesis and biological evaluation of carbamate derivatives incorporating multifunctional carrier scaffolds as pseudo-irreversible cholinesterase inhibitors for the treatment of alzheimer\u2019s disease","volume":"265","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0155","doi-asserted-by":"crossref","first-page":"115832","DOI":"10.1016\/j.ejmech.2023.115832","article-title":"Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, \u03b2-secretase, and amyloid \u03b2 aggregation as potential treatment of alzheimer\u2019s disease","volume":"261","author":"Zar\u0119ba","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109887_bb0160","doi-asserted-by":"crossref","first-page":"102190","DOI":"10.1016\/j.labinv.2024.102190","article-title":"D30 alleviates \u03b22-microglobulin\u2013facilitated neurotoxic microglial responses in isoflurane\/surgery-induced cognitive dysfunction in aged mice","volume":"105","author":"Chen","year":"2025","journal-title":"Lab. Investig."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109887_bb0165","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4103\/NRR.NRR-D-23-01890","article-title":"The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of alzheimers disease","volume":"20","author":"Liu","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioorg.2026.109887_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123085","article-title":"Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of galectin-3 ameliorates a\u03b2 pathogenesis-induced neuroinflammation in 5 \u00d7 FAD mice","volume":"357","author":"Liu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2026.109887_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115120","article-title":"Novel neuroprotective pyromeconic acid derivatives with concurrent anti-a\u03b2 deposition, anti-inflammatory, and anti-oxidation properties for treatment of alzheimers disease","volume":"248","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117277","article-title":"Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting alzheimer\u2019s disease","volume":"286","author":"Azam","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109887_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117066","article-title":"Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of alzheimer\u2019s disease","volume":"283","author":"Shankar","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109887_bb0190","doi-asserted-by":"crossref","first-page":"2313682","DOI":"10.1080\/14756366.2024.2313682","article-title":"Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating alzheimer\u2019s disease","volume":"39","author":"Yu","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109887_bb0195","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.4103\/NRR.NRR-D-23-01890","article-title":"The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of alzheimer\u2019s disease","volume":"20","author":"Liu","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioorg.2026.109887_bb0200","doi-asserted-by":"crossref","first-page":"105013","DOI":"10.1016\/j.bioorg.2021.105013","article-title":"N-propargylamine-hydroxypyridinone hybrids as multitarget agents for the treatment of alzheimers disease","volume":"113","author":"Guo","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109887_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:44:18Z","timestamp":1777452258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S0045206826004232"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109887","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of pyranone\u2013carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109887"}}